ATI RN
Immune System Drugs Questions
Question 1 of 5
Your patient taking belatacept becomes pregnant. After discussion with her partner, you, and her health care provider, she decides the best thing to do is continue taking the drug while pregnant. In addition to making this informed decision, what else should she do?
Correct Answer: B
Rationale: Step 1: Continuing all other drugs as prescribed ensures that the patient's underlying medical conditions are properly managed during pregnancy. Step 2: Discontinuing other drugs could lead to uncontrolled health issues, posing risks to both the mother and the fetus. Step 3: Stopping belatacept immediately without medical guidance could result in rejection of a transplanted organ. Step 4: Consulting with a genetic counselor is not necessary in this scenario as the primary concern is managing the patient's medical conditions during pregnancy.
Question 2 of 5
The nurse is preparing to administer routine, recommended immunizations to an immunocompromised 1-year-old child. What is the most important information to know before administering a vaccination?
Correct Answer: A
Rationale: The correct answer is A because knowing the type of vaccine to be administered is crucial for an immunocompromised child to assess its safety and efficacy. Different vaccines have varying levels of risk and efficacy for immunocompromised individuals. Choice B is not directly related to the safety or appropriateness of administering the vaccine. Choice C, while important, does not provide immediate information on the specific vaccine being administered. Choice D, although relevant, does not provide information on the specific vaccine's safety for an immunocompromised child.
Question 3 of 5
Which of the following patients would be eligible to receive the influenza vaccine?
Correct Answer: B
Rationale: The correct answer is B, the patient who is pregnant. Pregnant individuals are at higher risk of complications from influenza and are recommended to receive the influenza vaccine to protect themselves and their unborn child. A: The patient taking care of her son with HIV should also receive the influenza vaccine to prevent transmission, but this alone does not make her eligible for the vaccine. C: Patients with egg allergy can receive the influenza vaccine with appropriate precautions, so this does not automatically disqualify them. D: The child who is 18 months old is eligible for the influenza vaccine, but pregnant individuals are at higher risk, hence B is the correct answer.
Question 4 of 5
The health care provider plans to inject an interferon directly into the patient's wart. What interferon will the nurse prepare?
Correct Answer: C
Rationale: Rationale: The correct answer is C, Interferon alfa n3 (Alferon N), because it is specifically approved for the treatment of warts caused by human papillomavirus (HPV). Alferon N has been shown to have antiviral activity against HPV, making it the most suitable choice for injecting directly into the wart. Interferon alfa 2a (A), Interferon alfacon 1 (B), and Interferon beta 1a (D) are not specifically indicated for the treatment of warts caused by HPV, making them incorrect choices for this scenario.
Question 5 of 5
The nurse has an order to administer oprelvekin (Neumega) to a patient for the first time. Before administering the drug, what allergy would the nurse want to specifically question the patient about?
Correct Answer: B
Rationale: The correct answer is B: Escherichia coli-produced products. Oprelvekin is produced using genetically modified E. coli bacteria. The nurse should question the patient about any allergies to E. coli-produced products to prevent an allergic reaction. Choices A, C, and D are incorrect because oprelvekin is not derived from egg products, lactose, or penicillin.